当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:137.02亿  总市值:137.02亿
流通股本:8.76亿   总股本:8.76亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,655,615,225.62,402,432,066.081,167,024,840.85,379,858,169.92
  收到的税费返还278,786,727.78222,786,336.9989,282,796.6244,873,943.28
  收到其他与经营活动有关的现金133,406,616.07107,807,72394,724,379.59224,820,958.39
  经营活动现金流入小计4,067,808,569.452,733,026,126.071,351,032,016.995,849,553,071.59
  购买商品、接受劳务支付的现金1,902,526,049.081,238,684,187.75707,719,546.672,451,667,702.35
  支付给职工以及为职工支付的现金762,122,814.58536,709,554.88313,670,629.19916,088,149.72
  支付的各项税费247,510,291.58192,936,265.0987,891,506.22362,708,151.14
  支付其他与经营活动有关的现金259,494,894.85211,257,448.59105,803,345.43294,842,846.45
  经营活动现金流出小计3,171,654,050.092,179,587,456.311,215,085,027.514,025,306,849.66
  经营活动产生的现金流量净额896,154,519.36553,438,669.76135,946,989.481,824,246,221.93
二、投资活动产生的现金流量:
  收回投资收到的现金1,450,881,773.94514,874,773.94340,492,194.9-
  取得投资收益收到的现金21,177,972.057,721,757.744,085,056.525,024,350.34
  处置固定资产、无形资产和其他长期资产收回的现金净额6,665,905.92568,596.61407,096.615,336,226.74
  处置子公司及其他营业单位收到的现金净额--8,316.54-
  收到的其他与投资活动有关的现金150,000150,000--
  投资活动现金流入小计1,478,875,651.91523,315,128.29344,992,664.5710,360,577.08
  购建固定资产、无形资产和其他长期资产支付的现金337,063,725.36231,181,915.44151,629,821.1660,089,439.9
  投资支付的现金1,797,370,005.52558,000,405.52335,769,405.521,382,371,138.76
  投资活动现金流出小计2,134,433,730.88789,182,320.96487,399,226.622,042,460,578.66
  投资活动产生的现金流量净额-655,558,078.97-265,867,192.67-142,406,562.05-2,032,100,001.58
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,00090,000,00090,000,000470,000,000
  筹资活动现金流入小计90,000,00090,000,00090,000,000470,000,000
  偿还债务支付的现金140,000,000140,000,00050,000,000815,812,534.16
  分配股利、利润或偿付利息支付的现金179,549,892.2689,206,484.761,230,030455,306,266.56
  其中:子公司支付给少数股东的股利、利润---4,900,000
  支付其他与筹资活动有关的现金230,304,922.65115,760,678.07-111,593,897.18
  筹资活动现金流出小计549,854,814.91344,967,162.8351,230,0301,382,712,697.9
  筹资活动产生的现金流量净额-459,854,814.91-254,967,162.8338,769,970-912,712,697.9
四、汇率变动对现金及现金等价物的影响-42,991,637.73-32,905,539.65-18,500,052.73-17,015,588.67
五、现金及现金等价物净增加额-262,250,012.25-301,225.3913,810,344.7-1,137,582,066.22
  加:期初现金及现金等价物余额1,456,099,928.741,456,099,928.741,456,099,928.742,593,681,994.96
  期末现金及现金等价物余额1,193,849,916.491,455,798,703.351,469,910,273.441,456,099,928.74
补充资料:
  净利润-380,694,022.63-728,543,117.48
  资产减值准备-37,944,608.09-337,761,490.03
  固定资产和投资性房地产折旧-198,362,885.21-370,373,372.02
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-198,362,885.21-370,373,372.02
  无形资产摊销-20,101,627.52-43,988,387.1
  长期待摊费用摊销-2,056,726.72-3,445,908.52
  处置固定资产、无形资产和其他长期资产的损失-2,795,632.28-5,159,651.38
  固定资产报废损失-342,678.92-1,222,476.82
  财务费用-28,722,200.15-23,059,530.07
  投资损失--10,161,121.37--3,555,802.23
  递延所得税-3,926,863.07--11,557,358.38
  其中:递延所得税资产减少-23,205.46-1,615,712.51
    递延所得税负债增加-3,903,657.61--13,173,070.89
  存货的减少--34,355,217.91-349,330,400.45
  经营性应收项目的减少-50,221,240.18-162,649,253.74
  经营性应付项目的增加--144,471,581.69--181,320,332.7
  其他-5,758,690.62-2,198,228.77
  现金的期末余额-1,455,798,703.35-1,456,099,928.74
  减:现金的期初余额-1,456,099,928.74-2,593,681,994.96
  现金及现金等价物的净增加额--301,225.39--1,137,582,066.22
公告日期2026-10-222026-08-042026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑